EXHIBIT 99.2

WebMD CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data, unaudited)

	Three Months Ended					Six Months Ended
	June 30,					June 30,
	2004		2003			2004		2003
Revenue	$	281,881	$	233,418		$	553,095	$	454,949
Costs and expenses:
Cost of operations		163,961		135,441			326,603		261,286
Development and engineering		12,991		10,403			24,087		21,320
Sales, marketing, general and administrative		83,298		69,359			160,292		137,467
Depreciation, amortization and other		13,148		14,944			25,733		41,864
Legal expense		2,215		—			4,252		—
Interest income		4,511		4,985			9,994		10,033
Interest expense		4,838		2,926			9,586		5,741
Other income, net		447		1,118			484		1,301
Income (loss) from continuing operations before income tax provision		6,388		6,448			13,020		(1,395	)
Income tax provision		613		1,001			1,544		1,988
Income (loss) from continuing operations		5,775		5,447			11,476		(3,383	)
Loss from discontinued operations, net of income taxes		—		(31,717	)		—		(30,245	)
Net income (loss)	$	5,775	$	(26,270	)	$	11,476	$	(33,628	)
Basic income (loss) per common share:
Income (loss) from continuing operations	$	0.02	$	0.02		$	0.04	$	(0.01	)
Loss from discontinued operations		—		(0.11	)		—		(0.10	)
Net income (loss)	$	0.02	$	(0.09	)	$	0.04	$	(0.11	)
Diluted income (loss) per common share:
Income (loss) from continuing operations	$	0.02	$	0.02		$	0.03	$	(0.01	)
Loss from discontinued operations		—		(0.10	)		—		(0.10	)
Net income (loss)	$	0.02	$	(0.08	)	$	0.03	$	(0.11	)
Weighted-average shares outstanding used in computing income (loss) per common share:
Basic		312,281		304,001			310,886		303,447
Diluted		337,763		325,796			332,582		303,447

WebMD CORPORATION
CONSOLIDATED SEGMENT INFORMATION
(In thousands, except per share data, unaudited)

	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2004			2003			2004			2003
Revenues
Transaction services	$	166,037		$	118,021		$	329,816		$	233,514
Physician services		71,773			76,797			142,779			148,808
Portal services		31,852			26,538			58,161			48,718
Plastic technologies (a)		20,737			18,596			39,158			35,922
Inter-segment eliminations		(8,518	)		(6,534	)		(16,819	)		(12,013	)
	$	281,881		$	233,418		$	553,095		$	454,949
Income (loss) before taxes, non-cash and other items
Transaction services	$	28,914		$	22,342		$	58,764		$	46,393
Physician services		1,771			6,359			3,122			12,656
Portal services		7,626			6,192			12,168			10,210
Plastic technologies (a)		6,275			5,507			11,317			10,167
Corporate		(14,228	)		(12,381	)		(27,533	)		(24,843	)
Interest income		4,511			4,985			9,994			10,033
Interest expense		(4,838	)		(2,926	)		(9,586	)		(5,741	)
	$	30,031		$	30,078		$	58,246		$	58,875
Basic income per common share before taxes, non-cash and other items (b)	$	0.10		$	0.10		$	0.19		$	0.19
Diluted income per common share before taxes, non-cash and other items (b)	$	0.09		$	0.09		$	0.18		$	0.19
Taxes, non-cash and other items (c)
Depreciation, amortization and other	$	(13,148	)	$	(14,944	)	$	(25,733	)	$	(41,864	)
Amortization of prepaid content and services (included in cost of operations)		(346	)		(827	)		(601	)		(827	)
Amortization of prepaid content and services (included in sales, marketing, general and administrative)		(5,645	)		(5,176	)		(10,683	)		(11,322	)
Non-cash stock compensation (included in sales, marketing, general and administrative)		(2,736	)		(3,801	)		(4,441	)		(7,558	)
Legal expense		(2,215	)		—			(4,252	)
Income tax provision		(613	)		(1,001	)		(1,544	)		(1,988	)
Other income, net		447			1,118			484			1,301
Income (loss) from continuing operations		5,775			5,447			11,476			(3,383	)
Loss from discontinued operations, net of income taxes		—			(31,717	)		—			(30,245	)
Net income (loss)	$	5,775		$	(26,270	)	$	11,476		$	(33,628	)
Basic income (loss) per common share:
Income (loss) from continuing operations	$	0.02		$	0.02		$	0.04		$	(0.01	)
Loss from discontinued operations		—			(0.11	)		—			(0.10	)
Net income (loss)	$	0.02		$	(0.09	)	$	0.04		$	(0.11	)
Diluted income (loss) per common share:
Income (loss) from continuing operations	$	0.02		$	0.02		$	0.03		$	(0.01	)
Loss from discontinued operations		—			(0.10	)		—			(0.10	)
Net income (loss)	$	0.02		$	(0.08	)	$	0.03		$	(0.11	)
Weighted-average shares outstanding used in computing income (loss) per common share:
Basic		312,281			304,001			310,886			303,447
Diluted		337,763			325,796			332,582			303,447

(a)	Effective August 1, 2003, the Company completed the sale of two operating units of its Plastic Technologies segment, Porex Bio Products, Inc. and Porex Medical Products, Inc., in two separate transactions. Beginning in the quarter ended September 30, 2003, the Company’s consolidated financial statements reflect these operating units as discontinued operations for all prior periods. The above segment information reflects these operating units as discontinued operations for the prior periods.
(b)	Basic and diluted income per common share before taxes, non-cash and other items is based on the weighted-average shares outstanding used in computing basic and diluted income (loss) per common share.
(c)	Reconciliation of income before taxes, non-cash and other items to income (loss) from continuing operations.

WebMD CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)

	June 30,		December 31,
	2004		2003
	(Unaudited)		(Audited)
Assets
Cash and cash equivalents	$	206,611	$	63,298
Short-term investments		606		207,383
Accounts receivable, net		187,149		181,173
Inventory		12,022		12,158
Current portion of prepaid content and distribution services		16,114		18,116
Other current assets		24,934		25,973
Total current assets		447,436		508,101
Marketable debt securities		592,105		451,290
Marketable equity securities		3,206		4,744
Property and equipment, net		75,128		77,278
Prepaid content and distribution services		22,667		31,992
Goodwill		891,406		844,448
Intangible assets, net		185,175		184,130
Other assets		37,221		33,323
	$	2,254,344	$	2,135,306
Liabilities and Stockholders’ Equity
Accounts payable	$	9,767	$	10,390
Accrued expenses		190,716		208,430
Deferred revenue		101,516		86,708
Total current liabilities		301,999		305,528
Convertible subordinated notes		649,999		649,999
Other long-term liabilities		1,078		1,182
Convertible redeemable exchangeable preferred stock		98,181		—
Stockholders’ equity		1,203,087		1,178,597
	$	2,254,344	$	2,135,306

WebMD CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands, unaudited)

	Six Months Ended
	June 30,
	2004			2003
Cash flows from operating activities:
Net income (loss)	$	11,476		$	(33,628	)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Loss from discontinued operations		—			30,245
Depreciation, amortization and other		25,733			41,864
Amortization of debt issuance costs		1,498			774
Non-cash content and distribution services		11,284			12,149
Non-cash stock based compensation		4,441			7,558
Gain on investments		(363	)		(183	)
Gain on sale of property and equipment		(121	)		—
Changes in operating assets and liabilities:
Accounts receivable		(3,389	)		(5,743	)
Inventory		136			(896	)
Prepaid content and distribution services		79			(445	)
Accounts payable		(900	)		1,930
Accrued expenses		(19,179	)		(26,283	)
Deferred revenue		10,899			478
Other, net		(946	)		4,946
Net cash provided by continuing operations		40,648			32,766
Net cash provided by discontinued operations		—			4,553
Net cash provided by operating activities		40,648			37,319
Cash flows from investing activities:
Proceeds from maturities and sales of available-for-sale securities		329,163			2,631
Proceeds from maturities and redemptions of held-to-maturity securities		—			102,919
Purchases of available-for-sale securities		(274,600	)		(6,730	)
Purchases of held-to-maturity securities		—			(124,931	)
Purchases of property and equipment		(12,047	)		(8,861	)
Proceeds received from sale of property and equipment		417			—
Cash paid in business combinations, net of cash acquired		(58,060	)		(14,701	)
Other changes in equity of discontinued operations		—			(4,596	)
Net cash used in continuing operations		(15,127	)		(54,269	)
Net cash provided by discontinued operations		—			3,886
Net cash used in investing activities		(15,127	)		(50,383	)
Cash flows from financing activities:
Proceeds from issuance of common stock		25,011			28,578
Net proceeds from issuance of preferred shares		98,115			—
Payments of notes payable and other		(257	)		(25	)
Purchases of treasury shares		(4,877	)		(18,125	)
Net proceeds from issuance of convertible debt		—			290,500
Net cash provided by continuing operations		117,992			300,928
Net cash used in discontinued operations		—			(6,538	)
Net cash provided by financing activities		117,992			294,390
Effect of exchange rates on cash		(200	)		663
Net increase in cash and cash equivalents		143,313			281,989
Changes in cash attributable to discontinued operations		—			(1,901	)
Cash and cash equivalents at beginning of period		63,298			175,596
Cash and cash equivalents at end of period	$	206,611		$	455,684